Literature DB >> 24669042

Cerebral arteriopathy in neurofibromatosis type 1.

Rk Sanjeev1, S Kumaravelu2.   

Abstract

Entities:  

Year:  2012        PMID： 24669042      PMCID： PMC3862822          DOI： 10.1016/S0377-1237(11)60116-0

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  9 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

2.  Headaches in patients with neurofibromatosis-1.

Authors:  F J DiMario; S Langshur
Journal:  J Child Neurol       Date:  2000-04       Impact factor: 1.987

Review 3.  Paediatric stroke: genetic insights into disease mechanisms and treatment targets.

Authors:  Pinki Munot; Yanick J Crow; Vijeya Ganesan
Journal:  Lancet Neurol       Date:  2011-03       Impact factor: 44.182

Review 4.  National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987.

Authors: 
Journal:  Neurofibromatosis       Date:  1988

5.  Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children.

Authors:  K DeBella; J Szudek; J M Friedman
Journal:  Pediatrics       Date:  2000-03       Impact factor: 7.124

Review 6.  Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.

Authors:  Tena L Rosser; Gilbert Vezina; Roger J Packer
Journal:  Neurology       Date:  2005-02-08       Impact factor: 9.910

7.  Cerebral arteriopathy in children with neurofibromatosis type 1.

Authors:  David Rea; John F Brandsema; Derek Armstrong; Patricia C Parkin; Gabrielle deVeber; Daune MacGregor; William J Logan; Rand Askalan
Journal:  Pediatrics       Date:  2009-08-24       Impact factor: 7.124

Review 8.  Neurofibromatosis type 1.

Authors:  Kevin P Boyd; Bruce R Korf; Amy Theos
Journal:  J Am Acad Dermatol       Date:  2009-07       Impact factor: 11.527

Review 9.  Cerebrovascular dysplasia in neurofibromatosis type 1.

Authors:  A G Cairns; K N North
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-05-09       Impact factor: 10.154
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.